Basing approval of drugs for type 2 diabetes on real world outcomes

BMJ. 2015 Nov 3;351:h5829. doi: 10.1136/bmj.h5829.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Approval / organization & administration*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • United States Food and Drug Administration / legislation & jurisprudence*

Substances

  • Hypoglycemic Agents